US FDA's Strategic Transition of Animal to Non‐Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize Innovation

Authors

Institutions

Publication Details

Journal
The Journal of Clinical Pharmacology
Published
2025-11-11
DOI
https://doi.org/10.1002/jcph.70127
Primary Topic
Animal testing and alternatives
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

US FDA's Strategic Transition of Animal to Non‐Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize Innovation

Rajesh Krishna
The Journal of Clinical Pharmacology
Animal testing and alternatives
article

US FDA's Strategic Transition of Animal to Non‐Animal Alternatives for Monoclonal Antibody Development: A Much Needed Fuel to Incentivize Innovation

Rajesh Krishna
article en

Abstract

No abstract available for this paper.
The Journal of Clinical PharmacologyVol. 66(3)
Certara (United States) (US)
Openalex Percentile: Top 62%
Animal testing and alternatives
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.